Theodoros N. Teknos MD

Theodoros N. Teknos MD
ProfessorCollege of Medicineteknos.1@osu.edu
B-222 Starling Loving Hall 320 W 10th Avenue Columbus Ohio 43210
Phone:614-293-8074Fax:
  • Experimental Therapeutics

Current Publications

  • Ozer EFunctional and Quality of Life Outcomes of Transoral Robotic Surgery for Carcinoma of Unknown Primary.Laryngoscope 4/5/2014
  • Pan QElevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.Cancer 120 992-1001 4/1/2014
  • Teknos TNDown regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.Oral Oncol 2/21/2014
  • Chepeha DBEfficacy of Induction Selection Chemotherapy vs Primary Surgery for Patients With Advanced Oral Cavity Carcinoma.JAMA Otolaryngol Head Neck Surg 140 134-42 2/1/2014
  • Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison MLGenome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.Genome Res 24 185-99 2/1/2014
  • Teknos TNRhoC Regulates Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma by Overexpressing IL-6 and Phosphorylation of STAT3.PLoS One 9 e88527 1/1/2014
  • Kumar PA novel curcumin analog (h-4073) enhances the therapeutic efficacy of Cisplatin treatment in head and neck cancer.PLoS One 9 e93208 1/1/2014
  • Solove RJEmerging role of nanog in tumorigenesis and cancer stem cells.Int J Cancer 12/21/2013
  • Dziegielewski PT, Teknos TN, Durmus K, Old M, Agrawal A, Kakarala K, Marcinow A, Ozer ETransoral Robotic Surgery for Oropharyngeal Cancer: Long-term Quality of Life and Functional Outcomes.JAMA Otolaryngol Head Neck Surg 139 1099-108 11/1/2013
  • Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal AUse of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.JAMA Otolaryngol Head Neck Surg 139(9) 895-902 9/1/2013
  • Kaka AS, Kumar B, Kumar P, Wakely PE Jr, Kirsch CM, Old MO, Ozer E, Agrawal A, Carrau RE, Schuller DE, Siddiqui F, Teknos TNHighly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.Oral Surg Oral Med Oral Pathol Oral Radiol 116(3) 327-35 9/1/2013
  • Tassone P, Old M, Teknos TN, Pan Qp53-based therapeutics for head and neck squamous cell carcinoma.Oral Oncol 49(8) 733-7 8/1/2013
  • Islam M, Sharma S, Kumar B, Teknos TNAtorvastatin inhibits RhoC function and limits head and neck cancer metastasis.Oral Oncol 49(8) 778-86 8/1/2013
  • Ozer E, Alvarez B, Kakarala K, Durmus K, Teknos TN, Carrau RLClinical outcomes of transoral robotic supraglottic laryngectomy.Head Neck 35(8) 1158-61 8/1/2013
  • Zhang M, Taylor CE, Piao L, Datta J, Bruno PA, Bhave S, Su T, Lang JC, Xie X, Teknos TN, Pan Q, Mapp AKGenetic and chemical targeting of epithelial-restricted with serine box reduces EGF receptor and potentiates the efficacy of afatinib.Mol Cancer Ther 12(8) 1515-25 8/1/2013
  • Bradford CR, Kumar B, Bellile E, Lee J, Taylor J, D'Silva N, Cordell K, Kleer C, Kupfer R, Kumar P, Urba S, Worden F, Eisbruch A, Wolf GT, Teknos TN, Prince ME, Chepeha DB, Hogikyan ND, Moyer JS, Carey TEBiomarkers in advanced larynx cancer: Triological society thesis.Laryngoscope in press 6/18/2013
  • Arshad H, Ozer HG, Thatcher A, Old M, Ozer E, Agarwal A, Jafari H, Birkheimer D, Basinger H, Forest LA, Schuller DE, Teknos TNIntensive care unit versus non-intensive care unit postoperative management of head and neck free flaps: Comparative effectiveness and cost comparisons.Head Neck in press 6/18/2013
  • Durmus K, Rangarajan SV, Old MO, Agrawal A, Teknos TN, Ozer ETransoral robotic approach to carcinoma of unknown primary.Head Neck in press 5/29/2013
  • Xie X, Piao L, Cavey GS, Old M, Teknos TN, Mapp AK, Pan QPhosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.Oncogene in press 5/27/2013
  • Smith A, Teknos TN, Pan QEpithelial to mesenchymal transition in head and neck squamous cell carcinoma.Oral Oncol 49(4) 287-92 4/1/2013
  • Xie X, Piao L, Bullock BN, Smith A, Su T, Zhang M, Teknos TN, Arora PS, Pan QTargeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.Oncogene in press 3/11/2013
  • McClurg SW, Leon M, Teknos TN, Iwenofu OHChondromyxoid fibroma of the nasal septum: case report and review of literature.Head Neck 35(1) E1-5 1/1/2013
  • Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge C, Yu JG, Powell K, Mazar AP, Teknos TN, Old M, Glorioso JC, Chiocca EA, Kaur BCopper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.Clin Cancer Res 18(18) 4931-41 9/15/2012
  • Datta J, Smith A, Lang JC, Islam M, Dutt D, Teknos TN, Pan QmicroRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.Oncogene 31(36) 4045-53 9/6/2012
  • Kumar B, Yadav A, Lang JC, Cipolla M, Schmitt AC, Arradaza N, Teknos TN, Kumar PYM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels.Mol Cancer Ther 11(9) 1988-98 9/1/2012
  • Piao L, Zhang M, Datta J, Xie X, Su T, Li H, Teknos TN, Pan QLipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.Mol Ther 20(6) 1261-9 6/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu